• #Nucleic Acid Drug #Neotype Vaccine
  • August 18th-19th
  • Wuhan China

China Nucleic Acid Drug and Neotype Vaccine Industrial Conference 2022

  0 +

Professional Attendees

  0 +

Keynote Speeches

  0 +

Featured Booths

  0 +

Pharmaceutical Companies

  0 +

Media Reports

What is China Nucleic Acid Drug and Neotype Vaccine Industrial Conference?


A large number of new drug technologies have emerged in the field of biomedicine in recent years, and nucleic acid drugs are a pillar of the third revolution in biotechnology. According to statistics, more than 100 antibody drugs have been approved for marketing in the world, and many nucleic acid drugs are undergoing clinical trials or will be launched in the next few years. At the same time, with the advent of the post-epidemic era, the "big reshuffle" of the global vaccine industry is coming. Under the pressure of epidemic prevention, countries are actively seeking breakthroughs in various cutting-edge vaccine technologies, and the vaccine industry has become a rapidly developing industry. In particular, mRNA vaccines have shined in this epidemic, which has further promoted the development of the industry.


Committed to building a high-level professional exchange platform for pharmaceutical companies, biotechnology companies, scientific research institutions, technical service providers, investment institutions and other biopharmaceutical industry leaders and pathfinders working in the field of nucleic acid drugs and new vaccines, deepening Academic exchanges and industrialization cooperation, meeting the needs of upstream and downstream industry chains, promoting the research and development process of domestic nucleic acid drugs and new vaccines, and improving the technical level, China Nucleic Acid Drug and Neotype Vaccine Industrial Conference 2022 organized by Taas Labs will be held on August 18th- 19th in Wuhan, China. We sincerely invite you to visit us!


Agenda Highlights

  • Nucleic Acid Drug Advantages and R&D Difficulties

  • Pathogenic Gene Sequencing and Third-Generation Sequencing Technology

  • Analysis and Strategy of Efficient and Long-Acting mRNA Delivery Technology

  • Research Progress of Antisense Oligonucleotide (ASO) Drugs

  • Technological Barriers and Cost Control of siRNA/miRNA 

  • Frontiers in mRNA COVID-19 Vaccine Technology 

  • Cancer Vaccine Clinical Development Strategy

  • Vaccine Adjuvant Application Research and Cases

  • GMP Production Temperature and Storage Technology


Speakers

Shwen Gwee from Novartis
Prof. Yaping LI

Director

Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Shwen Gwee from Novartis
Dr. Juan LIU

Senior Scientist

Zhejiang Haichang Biomedical Technology Co., Ltd.

Shwen Gwee from Novartis
Dr. Qiuheng JIN

R&D Director of Biomedicine Division

Nanjing Vazyme Biotech Co., Ltd.

Shwen Gwee from Novartis
Dr. Shawn XIAO

Co-Founder

Jiangsu Synthgene Biotechnology Co., Ltd.

Shwen Gwee from Novartis
Dr. Shan GAO

Senior Vice President / CSO

Suzhou Ribo Life Science Co. Ltd.

Shwen Gwee from Novartis
Dr. Shenggao TANG

General Manager

Sirnamics BioPharmaceuticals Guangzhou

Shwen Gwee from Novartis
Dr. Jia ZHANG

Product Manager

Agilent

Shwen Gwee from Novartis
Dr. Ales Štrancar

Founder & CEO

BIA Separations d.o.o.

Shwen Gwee from Novartis
Dr. Xin ZHAO

Founder

Beijing Quick Medical Co., Ltd.

Shwen Gwee from Novartis
Prof. Jia FEI

Professor, Department of Biochemistry, Basic Medicine College, Doctoral Supervisor

Jinan University

Shwen Gwee from Novartis
Prof. Binlei LIU

Chairman and General Manager

Wuhan Binhui Biopharmaceutical Co., Ltd.

Shwen Gwee from Novartis
Dr. Long XU

Project Senior Manager

BravoVax Co., Ltd.

Shwen Gwee from Novartis
Dr. Lei SUN

General Manager

AbMax

Shwen Gwee from Novartis
Dr. Laixin WANG

Executive Vice President / CSO

Chongqing Denali Medpharma Co., Ltd.

Shwen Gwee from Novartis
Ms. Jiachang LI

Patent Search Expert, Technical Analyst

TiPLab

Shwen Gwee from Novartis
Mr. William LIU

Executive Director

Frost & Sullivan

Shwen Gwee from Novartis
Dr. Yurui ZHANG

R&D Vice President

Lotuslake Biomedical

Shwen Gwee from Novartis
Dr. Naibo YANG

COO

GenoImmune Therapeutics Ltd

Shwen Gwee from Novartis
Dr. Shiwei LANG

Director of Macromolecular Bioanalysis Division

Wuhan Hongren Biopharmaceutical Inc.

Shwen Gwee from Novartis
Dr. Haomeng WANG

Vice President

CanSino Biologics(Shanghai)Co., Ltd

Ways to Attend

Increase Your Visibility. Improve Your Reputation

Normal Ticket

  • 1 Pass

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs & Documentation


Exhibition Sponsor

  • 3 Passes

  • 4㎡/6㎡/9㎡ Booth for show

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Presentation Sponsor

  • 5 Passes

  • 30 min Speech Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation



Gold Sponsor

  • 5 or More Passes

  • 30 min Speech Opportunity

  • 6or 9 Booth for show

  • Chairman Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation



Secure your ticket today

Early Bird tickets available now

Secure your spot with our special offer, and don’t go alone, enjoy the best group discount.

Register

Sponsors & Partners

Part of Media Partners

搜狐网
新浪
中国生物器材网
肽度网
药智网
医谷网
药源网
大健康派
露森科研
制药在线
生物探索
今日头条
医药地理
镁客网
来宝网
中国仪器批发网
细胞世界
人民医生网
爱爱医网
基因线上
基因君
测序宝
分析测试百科网
会会药咖
快速问医生
医脉同道
医诺医学
全球医学会议网
智能网
医疗器械创新网
化学网
生物通

Related Meetings